Marco Galluzzo

72PUBLICATIONS
134CO-AUTHORS
Epidemiological methodsMajor global burdens of diseasePharmacogenomicsRegenerative medicine (incl. stem cells)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Nov 05, 2026
Treat-to-Target in Atopic Dermatitis: An Italian Survey and Expert Opinion on Clinical Practice and Unmet Needs.

|Oct 23, 2026
Upadacitinib for the Management of Atopic Dermatitis in Patients Aged ≥60 Years: A Long-Term Multicenter Real-World Study.

|Sep 23, 2026
Lebrikizumab in Atopic Dermatitis: Associations of Patient Characteristics and Treatment History with Clinical Outcomes.

|Apr 15, 2026
Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study.

|Mar 13, 2026
AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks.

Edoardo Mortato, Marina Talamonti, Lorenzo Savastano

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

Pageof 12

Frequent Collaborators

37 joint publications

Marina Talamonti

18 joint publications

Luca Bianchi

9 joint publications

Andrea Chiricozzi

8 joint publications

Giacomo Caldarola